NCT06797310: Evaluating the Effectiveness and Tolerance of Baricitinib in the Treatment of Acute Alopecia Areata With Active Hair Shedding: A Prospective Open-Label Study
- State
- Not started
- Phase
- Phase 2
- People
- 30 planned
- Started
- 23 Jan 2025
- Primary completion
- 31 Dec 2025
- Arms
- Baricitinib Treatment for Acute Alopecia Areata with Active Hair Shedding
- Results
- None posted
- 28 Jan 2025: Trial registered